Effect of ribavirin and immune serum on Junin virus-infected primates.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D006477:Arenaviruses, New World / Q000502:physiology; D002144:Callithrix; D002460:Cell Line; D002522:Chlorocebus aethiops; D003131:Combined Modality Therapy; D004353:Drug Evaluation, Preclinical; D006478:Hemorrhagic Fever, American / Q000188:drug therapy / Q000628:therapy*; D007116:Immunization, Passive; D007668:Kidney; D012254:Ribavirin / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D014766:Viremia / Q000188:drug therapy / Q000628:therapy; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D012263:Ribonucleosides; D012254:Ribavirin